To rectify this deficit, the expression of ARF6 was analysed using the TissueScan Cancer Survey III panel (a collection of four 96-well plates loaded with cDNAs, pre-normalised to β-actin expression, from cancers and corresponding healthy controls from 17 different tissues) obtained from Origene. Here, ACTB is linked to cancer.